Oral rimegepant for preventive treatment of migraine: a phase 2/3, randomised, double-blind, placebo-controlled trial
Pfizer
Robert Croop; Richard B Lipton; David Kudrow; David A Stock; Lisa Kamen; Charles M Conway; Elyse G Stock; Vladimir Coric; Peter J Goadsby